Back to search
FDAFDA · Food and drugs·Recall number D-1435-2012

Dr. Reddy's Ciprofloxacin Tablets, USP 500 mg*, 500 Tablets, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325 INDIA, NDC 55111-127-05

Published August 8, 2012 · Recall initiated: April 9, 2012

Summary

FDA records drug Class II recall D-1435-2012, published August 8, 2012 and initiated April 9, 2012. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 1656 bottles; Lot: C201293 Exp Date 08/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide and Puerto Rico
Lot
C201293 Exp Date 08/2013
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dr. Reddy's Ciprofloxacin Tablets, USP 500 mg*, 500 Tablets, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325 INDIA, NDC 55111-127-05 recalled?

Yes. FDA published recall D-1435-2012 on August 8, 2012. Reported hazard: Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets

What should I do if I have this product?

Voluntary: Firm initiated · Letter